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Synopsis: Transitional toric intraocular lens (IOL) was developed to improve refractive outcomes 
in cataract surgery. We report refractive, vectorial outcomes, and stability of spherical equivalent 
over 12 months after implantation of this IOL.
Purpose: To evaluate visual and refractive outcomes of a transitional conic toric intraocular 
lens (IOL) (Precizon®) for the correction of corneal astigmatism in patients undergoing cataract 
surgery.
Setting: The Ocular Microsurgery Institute (IMO), a private practice in Barcelona, Spain.
Design: This is a retrospective, non-randomized study.
Methods: Retrospective chart review of 156 patients with preoperative regular corneal astig-
matism .0.75 diopters (D) who underwent consecutive phacoemulsification and Precizon toric 
IOL implantation between January 2014 and December 2015 was performed. Two groups were 
divided according to attempted residual refraction: group 1 with emmetropia and group 2 with 
mild myopia for monovision. Uncorrected distance visual acuity (UDVA), corrected distance 
visual acuity (CDVA), and manifest refraction were analyzed preoperatively and 3, 6, and 
12 months postoperatively.
Results: Precizon toric IOL was implanted in 97 eyes of 61 patients. Six months postoperatively, 
none of the eyes lost any line of CDVA. In all, 98% of the eyes were within ±1.00 D of attempted 
spherical correction. The mean preoperative keratometric cylinder was 1.92 ± 1.04 D (range 
0.75–6.78), and the mean postoperative refractive cylinder was 0.77 ± 0.50 D (range 0–2.25), with 
81% of the eyes with #1.00 D of residual cylinder. Two IOLs required realignment due to intra-
operative positioning error. Eleven eyes required enhancement with corneal refractive surgery.
Conclusion: Preexisting regular corneal astigmatism was effectively and safely corrected by 
the implantation of the transitional conic toric IOL in patients undergoing cataract surgery.
Keywords: corneal astigmatism, refractive astigmatism, keratometry, cataract surgery, toric 
intraocular lens, biometry, phacoemulsification
Introduction
Modern cataract surgery is a refractive procedure that aims to reduce or eliminate 
refractive errors to improve visual function and to give patients as much independence 
of glasses as possible at the same time. Important factors precluding emmetropia 
include remaining corneal astigmatism and biometry prediction errors in astigmatic 
and ametropic eyes.1
Preoperative corneal astigmatism is observed in 87% of patients, with 36% 
presenting astigmatism .1.25 diopters (D).2,3 Leaving astigmatism uncorrected may 
cause a significant decrease in visual function, especially in low-contrast settings.4 
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Although accurate correction of astigmatism ,0.3 D does 
not seem to improve visual acuity (VA) in most cases, 
refractive and cataract surgery procedures should aim to 
leave uncorrected small amounts of natural astigmatism, 
typically ,0.5 D, to obtain optimal visual outcomes.5
Previous reports on toric intraocular lens (IOL) implanta-
tion in patients with corneal astigmatism undergoing cataract 
surgery have shown excellent visual and refractive outcomes. 
Compared to non-toric IOLs associated with limbal relaxing 
incisions, toric IOLs provide better uncorrected distance 
visual acuity (UDVA), greater spectacle independence, and 
lower amounts of residual astigmatism.6,7 Because misalign-
ment of a toric IOL results in an effective loss of the cylinder 
power (3.3% of effective loss of cylinder power per degree), 
accurate intraoperative alignment, IOL rotational stability, 
and tolerance to misalignment are key to achieve the best 
potential outcomes.6,7 The Precizon toric IOL (Ophtec BV, 
Groningen, the Netherlands) has a transitional conic surface 
that has been shown to provide superior image quality despite 
pupil size changes and the presence of decentration, as well as 
maximum rotation tolerance compared with the other IOLs.8 
These characteristics may result in excellent visual outcomes, 
predictability of refractive results, rotational stability, and 
good optical performance.6,7 The aim of this study was to 
evaluate the visual and refractive outcomes and the rotational 
stability of the Precizon toric IOL in a series of 97 eyes, 
which, to our knowledge, is the largest series to date.
Patients and methods
We performed a retrospective chart review of 156 patients 
who underwent consecutive phacoemulsification and 
Precizon toric IOL implantation between January 2014 and 
December 2016. All patients were operated on by the same 
surgeon (JLG) at the Instituto de Microcirugia Ocular (IMO, 
Barcelona, Spain).
All patients were fully informed about the details and the 
potential risks of the procedure. Written informed consent 
for the surgical procedure was obtained. Additionally, per-
mission for the use of patients’ data for research, analysis, 
and publication purposes was also obtained. The study was 
conducted in accordance with the institution’s Good Clinical 
Practices and the Declaration of Helsinki. Institutional review 
board (IRB) approval was obtained from Ophthalmologic 
Microsurgery Institute (IMO) Ethical Committee.
The inclusion criteria for outcome analysis were as fol-
lows: 1) preoperative corneal astigmatism .0.75; 2) uncom-
plicated cataract surgery; 3) phacoemulsification and Precizon 
toric IOL implantation; and 4) minimum follow-up of 
3 months. Both eyes of the same subject were included when 
applicable. Micro-monovision was performed with a target 
of −0.50 and −1.25 D in the non-dominant eye to improve 
spectacle independency according to each patient’s referred 
needs. The neutral asphericity of this implant helps to main-
tain the corneal natural positive spherical aberration, which 
combines natural depth of focus with monovision.9
Exclusion criteria were as follows: irregular astigmatism 
or abnormal corneal topography, previous corneal or intraoc-
ular surgery, low VA caused by preexisting ocular pathology 
that impeded manifest refraction, and complicated cataract 
surgery.
Preoperative examination and follow-up
Preoperative assessment included manifest refraction, cor-
rected distance visual acuity (CDVA), and UDVA using a 
standardized Snellen chart and light-box system at 20 feet; 
slit-lamp examination; eye dominance checked by our resident 
optometrists with “hole-in-the-card” technique; Goldmann 
applanation tonometry; biometry using the IOLMaster 500 
(Carl Zeiss Meditec AG, Jena, Germany); corneal topography 
using Orbscan II (Bausch & Lomb Incorporated, Bridgewa-
ter, NJ, USA); and posterior segment evaluation.
Follow-up postoperative visits were held 1 day, and 
1, 3, 6, and 12 months after surgery. Manifest refraction, 
UDVA, and CDVA were repeated at each follow-up visit. 
Additionally, IOL orientation was checked at the slit-lamp 
examination with dilated pupil.
surgical technique
Toric iOl calculation
Precizon toric IOL presents a cylinder correction ranging 
from 1.0 to 10.0 D in 0.5 steps, which correlates to astig-
matism correction on the corneal plane from 0.68 to 6.85 D 
in an average eye. The spherical and cylindrical correction 
of the IOL was calculated using the data obtained using 
the IOLMaster 500 with the Haigis biometry formula of 
optimized constants and the Ophtec toric IOL calculation 
software (http://calculator.ophtec.com). There was an overall 
coincidence of biometry and topography readings, for cases 
in which there was a divergence between keratometric read-
ings and axis; values for calculation were picked from the 
IOLMaster 500. The dominant eye was targeted to emmetro-
pia, and the non-dominant eye was targeted between −0.50 
and −1.25 D, depending on the case.
surgical technique and iOl orientation
Preoperative marking was performed using the RoboMarker 
(Surgilūm, Wilmington, NC, USA) with the patient in a 
seated position. The vast majority of patients received topical 





anesthesia. If retrobulbar anesthesia was required, the horizontal 
axis was marked before the retrobulbar injection.
Desired IOL orientation was marked using a Wallace 
Mendez Degree Gauge (Storz; Bausch & Lomb Incorpo-
rated) and a surgical marking pen. Phacoemulsification was 
performed using the Centurion® Vision System (Alcon Labo-
ratories, Inc., Fort Worth, TX, USA) using either a divide and 
conquer approach or the phaco rolling technique described by 
one of the authors in 2004.10 A bimanual irrigation–aspiration 
technique was used. ArtiVisc (Ophtec BV) and OcuCoat 
(Bausch & Lomb Incorporated) were used as ophthalmic 
viscosurgical devices (OVDs).
Intraoperative IOL alignment was performed before OVD 
aspiration and was rechecked at the end of surgery.
Postoperative treatment consisted of topical tobramycin 
0.3% and dexamethasone 0.1% (Tobradex; Alcon Cusi, El 
Masnou, Barcelona, Spain) four times daily, timolol 0.5% 
(Cusimolol; Alcon Cusi) two times daily, and dexamethasone 
0.05% and chloramphenicol 1% ointment (Deicol; Alcon 
Cusi) at bedtime for 3 weeks and then was stopped in absence 
of any inflammatory signs or signs of rejection.
Outcome analysis
Microsoft Excel (Microsoft Corporation, Redmond, WA, 
USA) was used for data collection and to perform vector 
analysis. Standard outcomes analysis was performed in 
accordance with the Standard Graphs for Reporting IOL 
Based Refractive Surgery.11 Outcome measures were UDVA, 
CDVA, manifest refraction, IOL rotation, and complications. 
VA measurements were converted from decimal to LogMar 
in order to facilitate statistical analysis and to Snellen to 
build the graphics. All data were analyzed preoperatively 
and 1, 3, 6, and 12 months postoperatively.
Continuous variables were described by mean, standard 
deviation (SD), and range. Accuracy of refractive correc-
tion (percentage of eyes within ±1 and ±0.5 D of attempted 
spherical equivalent [SEQ] and cylinder correction) was cal-
culated. Safety was assessed by loss of CDVA. Intraoperative 
and postoperative complications were registered.
The results were analyzed using Prism software version 6.0 
(GraphPad Software, Inc., La Jolla, CA, USA). Normality of 
data was assessed with the Shapiro–Wilk test. Comparison 
between preoperative and postoperative data was performed 
using the paired t-test or the Wilcoxon signed-rank test, 
depending on normality. p-values ,0.05 were considered as 
statistically significant.
Vector analysis is displayed in double-angle plot graphics 
for intended cylindrical correction, error vector (EV), normal-
ized EV, and treatment EV (Figure 1).
Preoperative keratometric astigmatism and postopera-
tive refractive astigmatism were analyzed 3 months post-











































Figure 1 Cylinder vector analysis.
Notes: (A) Tia vector. (B) eV. (C) neV. (D) TeV.
Abbreviations: Tia, target-induced astigmatism; eV, error vector; neV, normalized error vector; TeV, treatment error vector; D, diopters; sia, surgically induced astigmatism.





Table 1 Demographic data
Demographic data
age (years) 59.16 ± 12.35 (42–87)
Follow-up (months) 11.61 ± 7.65 (2.5–28)
axial length (mm) 23.29 ± 1.53 (20.23–27.60)
anterior chamber depth (mm) 3.12 ± 0.49 (2.06–4.10)
UDVa (logMar) 0.32 ± 0.30 (0–1)
CDVa (logMar) 0.14 ± 0.18 (0–0.7)
se (D) −0.01 ± 3.24 (−8.75 to 6.38)
Cylinder (D) −1.92 ± 1.04 (−6.79 to −0.68)
Note: results are displayed as mean ± sD (range).
Abbreviations: UDVa, uncorrected distance visual acuity; CDVa, corrected 
distance visual acuity; se, spherical equivalent; D, diopters; sD, standard deviation.
The Alpins method assesses changes in both magnitude and 
axis of astigmatism taking into account three vectors: target-
induced astigmatism (TIA) vector, which refers to desired 
change in astigmatic magnitude and axis that the surgery was 
intended to induce; surgically induced astigmatism (SIA) 
vector, which is the actual amount and axis of astigmatic 
change that the surgery induced; and the EV, which is the 
astigmatic change by magnitude and axis that would enable 
the initial surgery to achieve its intended target.13,14 It is an 
absolute measure of success and is preferably 0.
Relationships between these three fundamental vectors 
were also calculated. The correction index (CI) is the ratio 
of SIA to TIA and is preferably 1.0. The magnitude of error 
(ME) is the arithmetic difference between the magnitudes of 
SIA and TIA. The angle of error (AE) represents the angle 
between the vectors of SIA and TIA. If the achieved correc-
tion is counterclockwise away from the intended axis, the AE 
value will be positive; if the achieved correction is deviated 
clockwise, this value will be negative. The index of success 
(IS) is calculated by dividing the EV by the TIA. It represents 
a relative measure of success and is preferably 0.14,15
Results
Baseline characteristics
Of a total of 156 charts reviewed, 97 eyes of 61 patients com-
plied with the inclusion criteria. The reasons for exclusion 
of the analysis were abnormal corneal topography (n = 47), 
Fuchs’ dystrophy with clinical corneal edema (n = 2), retinal 
diseases (n = 1), previous corneal transplantation (n = 2), 
previous refractive surgery (n = 4), previous retinal sur-
gery (n = 1), and previous iris-claw intraocular phakic lens 
implantation (n = 2). Emmetropia with toric transitional lens 
implantation after cataract surgery was planned for 29 eyes 
of 29 patients and in both eyes of two patients. Sixty-four 
eyes of 32 patients underwent toric transitional lens implan-
tation with myopic target in one eye and emmetropia in the 
fellow eye. Mean follow-up time was 11.61 ± 7.56 months 
(range 3–28 months).
Table 1 summarizes baseline characteristics for all 
patients. For evaluation purposes, visual and SEQ outcomes 
were analyzed separately for eyes targeted to emmetropia 
(group 1) and mild myopia (group 2).
Visual outcomes, efficacy, and safety
A significant improvement in LogMar UDVA and LogMar 
CDVA was observed in both groups. In all, 64% of the patients 
achieved an uncorrected near visual acuity (UNVA) of 20/40 
or better. Figure 2A shows 3-month postoperative cumulative 
UDVA and CDVA for eyes targeted to emmetropia (group 1). 
Figure 2B shows 3-month postoperative UNVA and CDVA for 
eyes targeted to mild myopia (group 2). Figure 2C portraits the 
efficacy of UDVA correction compared to preoperative CDVA 
for eyes targeted to emmetropia. Figure 2D shows percentage 
of lines of CDVA gained/lost 3 months postoperatively in 
all patients. Percentage of eyes that gained one or more lines 
was 23% (25 eyes in group 1 and 11 eyes in group 2). Four 
percent of eyes lost one or more lines (four eyes in group 1 
and zero eyes in group 2). Postoperatively, UDVA and CDVA 
remained stable throughout the follow-up period.
Manifest refraction and accuracy of 
refractive correction
Mean SEQ in groups 1 and 2 was reduced from −0.56 ± 3.42 
to −0.15 ± 0.42 (p = 0.35) and from 1.07 ± 3.2 to −0.97 ± 0.48 
(p = 0.0032), respectively. Mean refractive cylinder was 
significantly reduced compared to previous keratometric 
cylinder in both groups, from 1.98 ± 1.1 to 0.66 ± 0.54 
(p , 0.0001) and from 1.84 ± 0.88 to 0.79 ± 0.63 (p , 0.0001), 
respectively (Tables 2 and 3). Figure 3 shows refractive 
outcomes and accuracy graphs. Ninety-eight percent of the 
patients presented residual standard error (SE) within ±1 D 
of the attempted SE and 81% presented residual astigma-
tism #1 D. Figure 4A and B shows the evolution of SE 
during the follow-up period for groups 1 and 2, respectively. 
Postoperatively, SE and cylinder remained stable throughout 
the follow-up in both the groups.
Vector analysis
Vector analysis was performed at the 6-week follow-up visit 
with results from both groups together. Results of the vector 
analysis with the Alpins method are shown in Table 3 and 
Figure 1. The SIA was significantly different from the TIA 
(p , 0.05) with a trend to overcorrection. The EV was also 
significantly different from zero at 1.5–3 months (−0.72 D at 
58°; p , 0.05). Mean values for ME, absolute and arithmetic 
AE, EI, CI, and IS are displayed in Table 4.





Figure 2 Three months postoperative cumulative UnVa/UDVa and CDVa.
Notes: (A) Preoperative CDVa and postoperative UDVa and CDVa for group 1 (emmetropia). (B) Preoperative CDVa and postoperative UnVa and CDVa for group 2 
(mild myopia for monovision). (C) Difference between UDVa and CDVa for group 1 (emmetropia). (D) Change in CDVa for all 97 eyes.
Abbreviations: UnVa, uncorrected near visual acuity; UDVa, uncorrected distance visual acuity; CDVa, corrected distance visual acuity.
Table 2 Pre- versus 3-month postoperative data for group 1




UDVa (logMar) 0.41 ± 0.48 0.12 ± 0.12 0.88
CDVa (logMar) 0.13 ± 0.17 0.026 ± 0.06 ,0.0001
Cylinder (D) −1.98 ± 1.11 
(−6.79 to −0.93)
−0.66 ± 0.54 
(−2.25 to 0)
,0.0001
se (D) −0.57 ± 3.43 
(−8.75 to +6.38)
−0.15 ± 0.43 
(−1.5 to +0.75)
0.35
Note: results are displayed as mean ± sD (range).
Abbreviations: UDVa, uncorrected distance visual acuity; CDVa, corrected 
distance visual acuity; D, diopters; se, standard error; sD, standard deviation.
Table 3 Pre- versus 3-month postoperative data for group 2
Preoperative 3 months 
post-surgery
p-value
Mild myopia (group 2)
UnVa (logMar) – 0.16 –
UDVa (logMar) 0.13 ± 0.19 (0–0.7) 0.34 ± 0.25 (0–1) 0.0003
CDVa (logMar) 0.17 ± 0.20 (0–0.7) 0.07 ± 0.15 (0–0.7) 0.02
Cylinder (D) −1.84 ± 0.88 
(−3.79 to −0.68)
−0.79 ± 0.63 
(−1.88 to 0)
,0.0001
se (D) 1.07 ± 3.20  
(−6.5 to +6.38)
−0.87 ± 0.48  
(−2.5 to 0)
0.0032
Note: results are displayed as mean ± sD (range).
Abbreviations: UnVa, uncorrected near visual acuity; UDVa, uncorrected 
distance visual acuity; CDVa, corrected distance visual acuity; D, diopters; se, 
standard error; sD, standard deviation.
safety: complications
On day after surgery, two eyes of two patients underwent 
surgical repositioning of the IOL because they were more 
than 30° away from the planned axis; five patients presented 
the IOL 3°–6° away from the planned axis but did not 
need further intervention because the refractive result was 
satisfactory; all other patients presented the IOL 3° within 
the intended axis. Only two patients presented divergent 
axis between topography with Orbscan and IOLMaster 








Figure 3 accuracy of refractive correction.
Notes: (A) attempted versus achieved seQ: group 1. (B) attempted versus achieved seQ refraction: group 2. (C) seQ accuracy (all patients). (D) Pre- versus postoperative 
astigmatism. (E) Tia versus sia. (F) refractive astigmatism ae. The blue lines show attempted correction = achieved correction; the green lines show +0.5 and −0.5 from 
attempted correction; the pink lines show +1 and −1 from attempted correction; the black lines correspond to the linear regression analysis; the linear regression equations 
are on the gray boxes in the graphs.
Abbreviations: seQ, spherical equivalent; Tia, target-induced astigmatism; sia, surgically induced astigmatism; ae, angle of error; D, diopters.
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Figure 4 refractive stability of seQ.
Notes: (A) refractive stability of seQ for emmetropia target (group 1). (B) refractive stability of seQ for mild myopia target (group 2).
Abbreviations: seQ, spherical equivalent; sD, standard deviation; D, diopters.
Table 4 Cylinder vector analysis
Average
Tia vector 1.93 ± 1.04
sia vector 2.06 ± 1.21
error of magnitude 0.13 ± 0.64
arithmetic error of axis 5.18 ± 14.00
absolute error of axis 9.36 ± 11.60
axis shift −30.71 ± 27.67
error ratio 0.37 ± 0.18
Correction ratio 1.07 ± 0.31
is 0.37 ± 0.36
Note: results are displayed as mean ± sD.
Abbreviations: Tia, target-induced astigmatism; sia, surgically induced astig-
matism; is, index of success.
500 keratometry; in these cases, the keratometric values 
from the IOLMaster were preferred over the Orbscan. One 
patient presented zonular damage and needed implantation of 
a capsular tension ring to stabilize the capsular bag, and the 
lens remained on the planned axis during all the follow-up 
time. No other intraoperative complications were observed 
in either group.
Eleven patients in group 1 underwent further refractive 
surgery enhancement due to residual cylinder and ametropia 
(nine LASIK and two photorefractive keratotomy). Three 
patients in group 2 were subjected to refractive surgery 
enhancement in one eye to improve uncorrected near VA. 
None of the IOLs had to be explanted. Three patients pre-
sented one or 2 lines decrease in CDVA. The causes for loss 
of lines in CDVA were as follows: (1 and 2) 61-year-old 
patient who experienced cystoid macular edema in both eyes 
after surgery and regained previous CDVA after clinical treat-
ment; (3) 76-year-old patient with stable Fuchs’ dystrophy 
who presented with a one-line decrease in CDVA in both 
eyes due to subclinical corneal edema that resolved within 
4 months, regaining 20/20 vision after 6 months; and (4) 
48-year-old patient with microcornea, a very shallow anterior 
chamber and high hyperopia with 20.56 mm axial length. 
She experienced postoperative anterior displacement of the 
IOL with a change in the effective lens position, which was 
successfully treated with peripheral iridotomy and LASIK to 
correct residual ametropia and achieved UDVA 20/25.
Discussion
Precizon toric transitional IOLs have been successfully 
implanted in eyes with astigmatism during cataract surgery 
to correct a wide range of refractive errors with satisfactory 
visual and refractive results. Visual outcomes were excellent 
and in agreement with previous publications, with 72% of 
patients in group 1 achieving 20/25 UDVA or better and 84% 
of patients achieving 20/32 UDVA after surgery.6 Patients in 
group 2 also benefited from the new IOL implantation, with 
the majority of patients being able to read and perform routine 
activities free of glasses for either near or far distance. The 
procedure can also be regarded as safe; only 4% of all eyes 
presented loss of two lines or less of VA; these cases had 
transient decrease of VA, which was resolved with clinical 
treatment. In all, 11% of the eyes were submitted to further 





refractive enhancement due to dissatisfaction with the resid-
ual cylinder (n = 9) and to improve near vision (n = 2). All of 
them achieved the desired outcome after the procedure.
Refractive outcomes were considered satisfactory with 
67% of all eyes achieving an SE within 0.5 D of the target 
refraction and 98% of the eyes within 1.0 D. Our findings 
are comparable to previous reported results;6 we achieved 
51% of the eyes with a residual cylinder of #0.5 D and 81% 
of the eyes with #1.0 D.
Even though our clinical and refractive results might be 
considered satisfactory, the vector analysis showed a mean 
EV of −0.72 at 59° with an IS of 0.37, which is relatively far 
from 0 and an undesirable result. However, this is in line with 
previous toric IOL vector results, which ranged from 0.12 to 
0.42.16–20 There was an overall tendency to overcorrection, 
with a mean error of magnitude of −0.13 ± 0.64 and a mean 
arithmetic error of angle of 5.18 ± 14.00, which is also com-
parable to previous reports (range from 0.63 to 9.16).16–20
We considered a refractive surprise .0.75 D of residual 
refractive cylinder or ,50% of refractive astigmatic correc-
tion; 41% of our patients met these criteria. Interestingly, 
these cases presented particular features in common as fol-
lows: 51% high or very low astigmatism (,1.5 or .2.5 D), 
44% very long or short eyes (,22 or .24.5 mm), 51% 
very shallow or deep anterior chamber depth (ACD; ,3 or 
.3.5 mm), 15% oblique astigmatism, 2% against-the-rule 
astigmatism, and 2% dry eye. Of note, the manufacturer 
IOL calculator does not take into consideration the ACD; 
it presumes the same effective lens position to all patients. 
According to previous publications, effective lens position 
can affect the effective cylindrical power of the IOL in both 
deep and shallow eyes.21 We have already contacted the 
developers of the software about this issue; meanwhile, we are 
conducting a study comparing algorithms for the calculation 
that include the posterior cornea and total corneal power. Our 
results differ from previous published data on Precizon toric 
transitional IOL. This may be due to the fact that our practice 
is a cornea and refractive surgery reference center, and many 
of our patients have high astigmatism or are hypermetropic 
and come to us to have early cataract surgery. The other 
authors did not mention the influence of ACD, axial length, 
or orientation of astigmatism in their outcomes.19,22
One of the drawbacks of our study is that we could not 
take into account the effect of posterior corneal astigmatism 
in IOL calculations, which might have led to both axis and 
power minor miscalculations. This might be the reason 
why we found a tendency for hypercorrection in patients 
who presented with-the-rule astigmatism and could also 
be a source of bias when interpreting the rotation tolerance 
of the lens that the design of our study could not entirely 
clarify. The disagreement between the vector analysis and 
clinical/refractive results could be explained because of the 
conical design of the cylindrical correction, which mimics 
the anatomic curvature of the eye; hence, it might be able to 
overcome slight axis misalignment due to either misposition 
or miscalculation of the cylindrical correction of the lens.8
Conclusion
We showed that Precizon toric transitional IOL is a suitable 
and safe alternative for astigmatic correction during cataract 
surgery, with adequate refractive and visual outcomes being 
our toric IOL of choice in our daily practice. However, we 
believe that results with this lens can be improved with the 
incorporation of the effective lens position into its calcula-
tor and using the total corneal astigmatism for toric IOL 
calculation.
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